Gentian Diagnostics ASA

OSL-GENT
Oslo Børs NYSE
Healthcare Medical Devices
Global Rank
#24849
Country Rank
#151
Market Cap
93.32 M
Price
6.05
Change (%)
1.32%
Volume
4,815

Gentian Diagnostics ASA's latest marketcap:

93.32 M

As of 06/07/2025, Gentian Diagnostics ASA's market capitalization has reached $93.32 M. According to our data, Gentian Diagnostics ASA is the 24849th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 93.32 M
Revenue (ttm) 15.63 M
Net Income (ttm) 4.83 M
Shares Out 15.42 M
EPS (ttm) 0.3
Forward PE 37.97
Ex-Dividend Date 05/07/2025
Earnings Date 07/10/2025
Market Cap Chart
Data Updated: 06/07/2025

Gentian Diagnostics ASA's yearly market capitalization.

Gentian Diagnostics ASA has seen its market value grow from kr839.95 M to kr943.85 M since 2020, representing a total increase of 12.37% and an annual compound growth rate (CAGR) of 2.66%.
Date Market Cap Change (%)
06/07/2025 kr943.85 M 54.08%
12/30/2024 kr604.56 M -5.54%
12/29/2023 kr640.03 M 1.22%
12/30/2022 kr632.32 M -43.06%
12/30/2021 kr1.11 B 32.2%
12/30/2020 kr839.95 M

Company Profile

Gentian Diagnostics ASA was founded in 2001 in Norway. on the Oslo Børs. With 63 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.